Correlation Between Oncopeptides and AroCell AB
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and AroCell AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and AroCell AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and AroCell AB, you can compare the effects of market volatilities on Oncopeptides and AroCell AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of AroCell AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and AroCell AB.
Diversification Opportunities for Oncopeptides and AroCell AB
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oncopeptides and AroCell is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and AroCell AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AroCell AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with AroCell AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AroCell AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and AroCell AB go up and down completely randomly.
Pair Corralation between Oncopeptides and AroCell AB
Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the AroCell AB. In addition to that, Oncopeptides is 1.04 times more volatile than AroCell AB. It trades about -0.08 of its total potential returns per unit of risk. AroCell AB is currently generating about 0.0 per unit of volatility. If you would invest 44.00 in AroCell AB on September 3, 2024 and sell it today you would lose (4.00) from holding AroCell AB or give up 9.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncopeptides AB vs. AroCell AB
Performance |
| Timeline |
| Oncopeptides AB |
| AroCell AB |
Oncopeptides and AroCell AB Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncopeptides and AroCell AB
The main advantage of trading using opposite Oncopeptides and AroCell AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, AroCell AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AroCell AB will offset losses from the drop in AroCell AB's long position.| Oncopeptides vs. BioInvent International AB | Oncopeptides vs. Alligator Bioscience AB | Oncopeptides vs. Swedish Orphan Biovitrum | Oncopeptides vs. Anoto Group AB |
| AroCell AB vs. Smart Eye AB | AroCell AB vs. Genovis AB | AroCell AB vs. Kancera AB | AroCell AB vs. Zignsec AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |